Search Videos by Topic or Participant
Browse by Series:

Emerging Therapies in Prostate Cancer

Panelists: Raoul S. Concepcion, MD, Urology Associates, PC; Steve Dobbs, Urologic Associates of Oklahoma; Bryan A. Mehlhaff, MD, Oregon Urology Institute;
Published: Wednesday, Jan 16, 2013
For High-Definition, Click
Raoul D. Concepcion, MD, introduces the topic of emerging therapies in patients with castration-resistant prostate cancer. Currently, in the docetaxel failure state, cabazitaxel, abiraterone, and enzalutamide are approved.

Concepcion highlights several key agents in phase III clinical trials. Alpharadin or radium-223 is an alpha radiopharmaceutical that has a narrow depth of penetration but has a survival benefit alone as well as response for pain relief and reduction of skeletal-related events.

Concepcion also mentions Oteronel or TAK-700, an oral agent, and Aragon or 509, an androgen signaling inhibitor.
Slider Left
Slider Right
For High-Definition, Click
Raoul D. Concepcion, MD, introduces the topic of emerging therapies in patients with castration-resistant prostate cancer. Currently, in the docetaxel failure state, cabazitaxel, abiraterone, and enzalutamide are approved.

Concepcion highlights several key agents in phase III clinical trials. Alpharadin or radium-223 is an alpha radiopharmaceutical that has a narrow depth of penetration but has a survival benefit alone as well as response for pain relief and reduction of skeletal-related events.

Concepcion also mentions Oteronel or TAK-700, an oral agent, and Aragon or 509, an androgen signaling inhibitor.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x